Shanghai RAAS Blood Products Co Ltd Class A (002252) — Free Cash Flow Generation Index
Shanghai RAAS Blood Products Co Ltd Class A (002252) has a Free Cash Flow Generation Index of 0.92x as of March 2025. Free cash flow of CN¥713.04 Million represents 1% of operating cash flow (CN¥775.56 Million). Explore 002252 capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Shanghai RAAS Blood Products Co Ltd Class A Free Cash Flow Generation Index (2005–2023)
Historical FCF Generation Index trend for Shanghai RAAS Blood Products Co Ltd Class A across 18 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Shanghai RAAS Blood Products Co Ltd Clas.
Annual Free Cash Flow Generation for Shanghai RAAS Blood Products Co Ltd Class A (2005–2023)
Year-by-year Free Cash Flow Generation Index for Shanghai RAAS Blood Products Co Ltd Class A. Check Shanghai RAAS Blood Products Co Ltd Clas investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2023 | 0.80x | CN¥1.83 Billion | CN¥2.28 Billion | CN¥450.80 Million | ▼ -7.7% |
| 2022 | 0.87x | CN¥1.50 Billion | CN¥1.73 Billion | CN¥225.73 Million | ▲ +3.2% |
| 2021 | 0.84x | CN¥1.09 Billion | CN¥1.29 Billion | CN¥204.61 Million | ▲ +7.3% |
| 2020 | 0.78x | CN¥917.09 Million | CN¥1.17 Billion | CN¥251.76 Million | ▼ -4.6% |
| 2019 | 0.82x | CN¥717.86 Million | CN¥872.69 Million | CN¥154.84 Million | ▲ +104.6% |
| 2018 | 0.40x | CN¥105.56 Million | CN¥262.50 Million | CN¥156.94 Million | ▲ +0.9% |
| 2017 | 0.40x | CN¥107.11 Million | CN¥268.76 Million | CN¥157.84 Million | ▼ -48.2% |
| 2016 | 0.77x | CN¥490.74 Million | CN¥638.22 Million | CN¥147.49 Million | ▼ -5.0% |
| 2015 | 0.81x | CN¥617.03 Million | CN¥762.42 Million | CN¥145.39 Million | ▼ -5.9% |
| 2014 | 0.86x | CN¥400.90 Million | CN¥465.96 Million | CN¥65.06 Million | ▲ +99.3% |
| 2012 | 0.43x | CN¥113.77 Million | CN¥263.46 Million | CN¥149.70 Million | ▲ +6138.4% |
| 2011 | 0.01x | CN¥1.23 Million | CN¥178.03 Million | CN¥176.80 Million | ▼ -98.8% |
| 2010 | 0.55x | CN¥111.00 Million | CN¥200.21 Million | CN¥89.21 Million | ▲ +16.9% |
| 2009 | 0.47x | CN¥55.02 Million | CN¥116.01 Million | CN¥60.99 Million | ▼ -34.9% |
| 2008 | 0.73x | CN¥78.41 Million | CN¥107.64 Million | CN¥29.23 Million | ▼ -15.4% |
| 2007 | 0.86x | CN¥151.25 Million | CN¥175.71 Million | CN¥24.46 Million | ▲ +11.1% |
| 2006 | 0.77x | CN¥41.50 Million | CN¥53.58 Million | CN¥12.08 Million | ▲ +29.4% |
| 2005 | 0.60x | CN¥32.32 Million | CN¥54.02 Million | CN¥21.69 Million | — |